Clinical Trial Update: Ranolazine Implantable Cardioverter-Defibrillator Trial [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for ranolazine in implantable cardioverter-defibrillator patients completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Ischemic Cardiomyopathy
• Nonischemic Cardiomyopathy

Drugs mentioned

• Ranolazine (ranolazine)

Snippet

Sponsor: University of Rochester | Conditions: Ischemic Cardiomyopathy, Nonischemic Cardiomyopathy | Phase 3 | Status: COMPLETED | Results posted: 2018-06-15